Searched for
SANOFI GENZYME
Elon Musk's acrimonious Twitter bid heads for business school case study immortalisation"This is unique in many cases," said Arturo Bris, Professor of Finance and Director of IMD World Competitiveness Center. "It is definitely ...- Indian Institute of Foreign Trade concludes summer placementsAround 80 recruiters made offers to the batch of 282 students. Companies hired students aggressively and 16 companies recruited more than f...
- IGST a bitter pill for patients with rare disorders as medicines attract 5%-12%While life-saving medicines imported for personal use would continue to be exempt from basic customs duty, they are not exempt from IGST.
- Sanofi and Regeneron's eczema drug gets FDA approvalThe FDA approved Dupixent (dupilumab), is the first targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.
- European equities look more attractive than US stocks: Erin Gibbs, Equity CIO, SPIASI expect the euro to trade more in a normal range - it might slightly appreciate against dollar as we see tightening in the US and QE in th...
- Indian Pharma: Regaining our brand equityThe perception that India-made drugs are of “bad quality” is largely due to many related and unrelated convergence of events.
- Dr Reddy's plunges nearly 2% on patent infringement suitDr Reddy's Laboratories plunged as much as 1.85% in a weak market on Monday after Genzyme Corporation filed a suit against the company.
- Eleven stocks in focus in Monday morning tradeIndian markets are likely to trade in a range. Here is a list of eleven stocks which are likely to be in focus in trade today.
- Genzyme Corporation files patent infringement suit against DRLMozobil (plerixafor injection) is a hematopoietic stem cell mobiliser indicated to patients with non-Hodgkin's lymphoma (blood cancer) and ...
- Genzyme signs deal with SIAMG to train doctors in geneticsGenzyme, announced a tie-up with the Society for Indian Academy of Medical Genetics, for a joint fellowship program for Indian doctors.
- Sanofi India acquires office space in PowaiFrench multinational pharmaceutical company Sanofi's Indian subsidiary has acquired 150,000 sq ft of office space at its new project in Pow...
- French pharma giant Sanofi Aventis lines up $300 million for Shantha facility in HyderabadThe company will continue to reduce its reliance on big products such as Plavix, which is the world’s second-best-selling drug with 2010 sa...
- Global consolidation hits Indian contract drug manufacturing cosMany global research firms, such as Pfizer, GSK and Merck, have announced massive cost-cutting measures, including expenses in R&D.
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- Sanofi extends bid for GenzymeFrench pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving the off...
- Genzyme board rejects Sanofi $69-a-share offerBiotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...
- Genzyme plans to cut 1000 jobs over next 15 monthsCambridge-based biotechnology company Genzyme, which rejected a $ 18.5 bn takeover offer from French pharma giant Sanofi Aventis, plans to ...
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: ReportFrench drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
Load More
